Screening for Sudden Cardiac Death in the Young

The debate over cardiovascular screening to prevent sudden cardiac death in the young (SCDY) has fervent and well-intentioned supporters on both sides.However, this debate will continue unresolved until additional,compelling evidence is provided that either supports orrefutes the utility of screening for SCDY.\udIn an effort to provide direction to determine what type of\udevidence is necessary and the best methodology to obtain\udsuch evidence, the National Heart, Lung, and Blood Institute\ud(NHLBI) convened a Working Group meeting in April 2010\udin Bethesda, MD. The charge of the Working Group was to\uddevelop a research agenda and identify resources to evaluate\udwhether screening for SCDY would effectively reduce sudden cardiac death and add overall healthcare value, where value was defined as\udimproved clinical outcomes with an acceptable cost-benefit\udratio. The Working Group consisted of experts in pediatric\udcardiology and electrophysiology, adult cardiology, epidemiology, biostatistics, sports medicine, child psychiatry, health economics, ethics, oncology screening, and newborn screening